Print  |  Font Size Change Font Size
Search naabt.org  

The National Alliance of Advocates
for Buprenorphine Treatment

Buprenorphine (Suboxone®, Subutex®) is an opioid medication used to treat opioid
addiction in the privacy of a physician's office.1 Buprenorphine can be dispensed
for take-home use, by prescription.1 This, in addition to the pharmacological and safety
profile of buprenorphine, makes it an attractive treatment for patients addicted to opioids.2

Other Resources:

The manufacturer of SUBOXONE® has a resource to help people through the first 12 weeks of treatment. You can speak with a live care coach who is educated about Suboxone.

The Here to HelpProgram

For more information or to get started today:

CALL
(866) 956-9204

OR CLICK
HereToHelpProgram.com

If you're searching for, or are already in SUBOXONE® treatment for opioid dependence, you can join the Here to Help™ Program for access to tools and resources that can help you set new goals and stay motivated as you work to get your life back on track.

With the Here to Help Program, you get:

  • Help finding the right doctor for you.
  • Support during your SUBOXONE treatment for opioid dependence (addiction)
  • Telephone access to a personal Care Coach ready to offer guidance and encouragement Mon-Fri. 8:00am – 11:00pm Sat 8:00am-8:00pm ET
  • 24/7 online access to tools and information
  • Supportive e-mails to inspire you
  • Help finding the right counseling options
  • Links to peer support and educational resources
This page was last modified on : 05/29/2009
National Drug & Alcohol Recovery MonthAddiction Survivors National Institute of HealthAlcohol AnswersNIDA
  1. U.S. Food and Drug Administration, FDA Talk Paper, T0238, October 8, 2002, Subutex and Suboxone approved to treat opiate dependence.
  2. Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004.